Tempus AI

Tempus AI is a Chicago-based health technology company that uses artificial intelligence and data analysis to advance precision medicine, primarily in oncology and other disease areas. It builds a library of clinical and molecular data (including genomic sequencing) that helps physicians make more personalized treatment decisions. The company trades on Nasdaq under the ticker TEM and has grown through acquisitions such as Ambry Genetics.